Literature DB >> 5243066

Cell line derived from patient with myeloma.

G E Moore, H Kitamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5243066

Source DB:  PubMed          Journal:  N Y State J Med        ISSN： 0028-7628


× No keyword cloud information.
  6 in total

1.  Characterization of the growth of herpes simplex virus in human lymphoid cells.

Authors:  A Mizrahi; J R Mitchen; H W Von Heyden; J Minowada; G E Moore
Journal:  Appl Microbiol       Date:  1972-01

2.  A survey of commercially available tissue culture media.

Authors:  H J Morton
Journal:  In Vitro       Date:  1970 Sep-Oct

3.  Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.

Authors:  K Nilsson; H Bennich; S G Johansson; J Pontén
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

4.  Marker profiles of human leukemia and lymphoma cell lines.

Authors:  J Minowada; H Koshiba; K Sagawa; I Kubonishi; M S Lok; E Tatsumi; T Han; B I Srivastava; T Ohnuma
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Interphase cell death as related to the cell cycle of melphalan-treated human myeloma cells.

Authors:  J O Fernberg; R Lewensohn; S Skog
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

6.  Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment.

Authors:  Natella I Enukashvily; Natalia Semenova; Anna V Chubar; Dmitry I Ostromyshenskii; Ekaterina A Gushcha; Sergei Gritsaev; Stanislav S Bessmeltsev; Viktor I Rugal; Egor M Prikhodko; Ivan Kostroma; Anastasia Zherniakova; Anastasia V Kotova; Liubov A Belik; Alexander Shumeev; Irina I Maslennikova; Dmitry I Ivolgin
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.